PCR-free blood group genotyping using a nanobiosensor

Area of Science:

• Biotechnology
• Nanotechnology
• Immunology

Background:

• Advancements in genotyping assays aid alloimmunized patients by improving red blood cell unit procurement.
• Current methods for blood group genotyping can be time-consuming and costly.
• A novel nanotechnology approach was developed to create faster, simpler, and more economical genotyping.

Purpose of the Study:

• To assess a nanobiosensor's capability to identify single nucleotide polymorphisms in non-amplified genomic DNA.
• To determine if the nanobiosensor signal is detectable by standard flow cytometry.

Main Methods:

• Silver-core silica-shell fluorescent nanoparticles (Ag@SiO₂) were synthesized and functionalized with DNA probes.
• A cationic conjugated polymer was used for optical transduction upon target DNA hybridization.
• Nanobiosensors specific to Dombrock (DO) alleles DO*01 and DO*02 were prepared and tested with extracted DNA.

Main Results:

• The nanobiosensor successfully discriminated between specific DNA sequences, showing a statistically significant increase in signal.
• All nine volunteer genotypes for DO*01 and DO*02 were accurately identified.
• The results were validated against established polymerase chain reaction (PCR) assays.

Conclusions:

• The developed nanobiosensor offers a rapid, straightforward method for genotyping blood group antigens directly from unamplified genomic DNA.
• The assay's signal is readily detectable using conventional flow cytometry equipment.
• This PCR-free genotyping technology holds potential for application to any known genetic polymorphism.